NEW YORK, Nov. 18 (GenomeWeb News) - GE Healthcare accredited GenUs BioSystems to provide gene-expression services using the conglomerate's CodeLink platform, a GenUs spokesperson said today.
GenUs "is the only certified CodeLink laboratory focused solely on gene expression experimentation," said Jeff Bergau, a spokesperson for GenUs.
The company will use CodeLink for both gene expression and "DNA-based" experiments, according to a GenUs statement.
Scott Magnuson, president of GenUs, helped develop the CodeLink technology while he was head of genomics and bioinformatics for Motorola Life Sciences. He later left the company after it was bought by Amersham to begin GenUs in April, 2003, according to BioArray News, a GenomeWeb New publication.
The CodeLink platform became the property of GE Healthcare when the company acquired Amersham in April.